Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2018

01-10-2018 | Original Article

HbE Level and Red Cell Parameters in Heterozygous HbE With and Without α0-Thalassemia Trait

Authors: Sakorn Pornprasert, Monthathip Tookjai, Manoo Punyamung, Panida Pongpunyayuen

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2018

Login to get access

Abstract

We compared hemoglobin (Hb) E levels and red cell parameters between heterozygous HbE with and without α0-thalassemia trait and also determine their appropriated cut-off points for differentiating these two groups. High performance liquid chromatography analysis results and mean levels of red blood cell (RBC) parameters, including RBC count, total Hb, hematocrit, MCV, MCH and MCHC of heterozygous HbE with α0-thalassemia trait (n = 183) and without α0-thalassemia trait (n = 1437) were reviewed and compared. The α0-thalassemia status in these samples was detected by real-time PCR with SYBR Green1 and high resolution melting analysis. Mean levels of HbE, total Hb, MCV, MCH and MCHC of heterozygous HbE with α0-thalassemia trait were significantly lower than those of heterozygous HbE without α0-thalassemia trait (P < 0.001). In addition, HbE level at a cut-off value of < 24% was superior to MCV (< 80 fL) and MCH (< 27 pg) for differentiating the heterozygous HbE with and without α0-thalassemia trait with 100% sensitivity and 87.2% specificity. Despite certain limitations of this study like missing RDW and reticulocyte counts, and not testing for α+-thalassemia and Hb Constant Spring, we conclude that the HbE level at a cut-off point of < 24% is a useful marker for initial discrimination between heterozygous HbE with and without α0-thalassemia trait.
Literature
1.
go back to reference Fucharoen G, Fucharoen S, Sanchaisuriya K, Sae-Ung N, Suyasunanond U, Sriwilai P et al (2002) Frequency distribution and haplotypic heterogeneity of beta(E)-globin gene among eight minority groups of northeast Thailand. Hum Hered 53:18–22CrossRef Fucharoen G, Fucharoen S, Sanchaisuriya K, Sae-Ung N, Suyasunanond U, Sriwilai P et al (2002) Frequency distribution and haplotypic heterogeneity of beta(E)-globin gene among eight minority groups of northeast Thailand. Hum Hered 53:18–22CrossRef
2.
go back to reference Fucharoen S, Winichagoon P (1987) Hemoglobinopathies in southeast Asia. Hemoglobin 11:65–88CrossRef Fucharoen S, Winichagoon P (1987) Hemoglobinopathies in southeast Asia. Hemoglobin 11:65–88CrossRef
3.
go back to reference Fucharoen S, Winichagoon P (1992) Thalassemia in SouthEast Asia: problems and strategy for prevention and control. Southeast Asian J Trop Med Public Health 23:647–655PubMed Fucharoen S, Winichagoon P (1992) Thalassemia in SouthEast Asia: problems and strategy for prevention and control. Southeast Asian J Trop Med Public Health 23:647–655PubMed
4.
go back to reference Traeger J, Wood WG, Clegg JB, Weatherall DJ (1980) Defective synthesis of HbE is due to reduced levels of beta E mRNA. Nature 288:497–499CrossRef Traeger J, Wood WG, Clegg JB, Weatherall DJ (1980) Defective synthesis of HbE is due to reduced levels of beta E mRNA. Nature 288:497–499CrossRef
6.
go back to reference Nathalang O, Nillakupt K, Arnutti P, Boonsiri T, Panichkul S, Areekul W (2005) Screening for thalassemia and hemoglobinopathy in a rural area of Thailand: a preliminary study. J Med Assoc Thai 88:35–42 Nathalang O, Nillakupt K, Arnutti P, Boonsiri T, Panichkul S, Areekul W (2005) Screening for thalassemia and hemoglobinopathy in a rural area of Thailand: a preliminary study. J Med Assoc Thai 88:35–42
7.
go back to reference Van Delft P, Lenters E, Bakker-Verweij M, de Korte M, Baylan U, Harteveld CL et al (2009) Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol 31:484–495CrossRef Van Delft P, Lenters E, Bakker-Verweij M, de Korte M, Baylan U, Harteveld CL et al (2009) Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol 31:484–495CrossRef
8.
go back to reference Charoenkwan P, Wanapirak C, Thanarattanakorn P, Sekararithi R, Sae-Tung R, Sittipreechacharn S et al (2005) Hemoglobin E levels in double heterozygotes of hemoglobin E and SEA-type alpha-thalassemia. Southeast Asian J Trop Med Public Health 36:467–470PubMed Charoenkwan P, Wanapirak C, Thanarattanakorn P, Sekararithi R, Sae-Tung R, Sittipreechacharn S et al (2005) Hemoglobin E levels in double heterozygotes of hemoglobin E and SEA-type alpha-thalassemia. Southeast Asian J Trop Med Public Health 36:467–470PubMed
9.
go back to reference Leckngam P, Limweeraprajak E, Kiewkarnkha T, Tatu T (2017) The Hb E (HBB: c.79G > A), mean corpuscular volume, mean corpuscular hemoglobin cutoff points in double heterozygous Hb E/- -SEA alpha-thalassemia-1 carriers are dependent on hemoglobin levels. Hemoglobin 41:38–43CrossRef Leckngam P, Limweeraprajak E, Kiewkarnkha T, Tatu T (2017) The Hb E (HBB: c.79G > A), mean corpuscular volume, mean corpuscular hemoglobin cutoff points in double heterozygous Hb E/- -SEA alpha-thalassemia-1 carriers are dependent on hemoglobin levels. Hemoglobin 41:38–43CrossRef
10.
go back to reference Pornprasert S, Wiengkum T, Srithep S, Chainoi I, Singboottra P, Wongwiwatthananukit S et al (2011) Detection of alpha-thalassemia-1 Southeast Asian and Thai type deletions and beta-thalassemia 3.5-kb deletion by single-tube multiplex real-time PCR with SYBR Green1 and high-resolution melting analysis. Korean J Lab Med 31:138–142CrossRef Pornprasert S, Wiengkum T, Srithep S, Chainoi I, Singboottra P, Wongwiwatthananukit S et al (2011) Detection of alpha-thalassemia-1 Southeast Asian and Thai type deletions and beta-thalassemia 3.5-kb deletion by single-tube multiplex real-time PCR with SYBR Green1 and high-resolution melting analysis. Korean J Lab Med 31:138–142CrossRef
11.
go back to reference Van Vranken M (2010) Evaluation of microcytosis. Am Fam Physician 82:1117–1122PubMed Van Vranken M (2010) Evaluation of microcytosis. Am Fam Physician 82:1117–1122PubMed
12.
go back to reference Sanchaisuriya K, Chirakul S, Srivorakun H, Fucharoen G, Fucharoen S, Changtrakul Y et al (2008) Effective screening for double heterozygosity of Hb E/alpha0-thalassemia. Ann Hematol 87:911–914CrossRef Sanchaisuriya K, Chirakul S, Srivorakun H, Fucharoen G, Fucharoen S, Changtrakul Y et al (2008) Effective screening for double heterozygosity of Hb E/alpha0-thalassemia. Ann Hematol 87:911–914CrossRef
13.
go back to reference Bianco I, Cappabianca MP, Foglietta E, Lerone M, Deidda G, Morlupi L et al (1997) Silent thalassemias: genotypes and phenotypes. Haematologica 82:269–280PubMed Bianco I, Cappabianca MP, Foglietta E, Lerone M, Deidda G, Morlupi L et al (1997) Silent thalassemias: genotypes and phenotypes. Haematologica 82:269–280PubMed
14.
go back to reference Khera R, Singh T, Khuana N, Gupta N, Dubey AP (2015) HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation. Indian J Hematol Blood Transfus 31:110–115CrossRef Khera R, Singh T, Khuana N, Gupta N, Dubey AP (2015) HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation. Indian J Hematol Blood Transfus 31:110–115CrossRef
15.
go back to reference Sharma P, Das R, Trehan A, Bansal D, Chhabra S, Kaur J et al (2015) Impact of iron deficiency on hemoglobin A2% in obligate β-thalassemia heterozygotes. Int J Lab Hematol 37:105–111CrossRef Sharma P, Das R, Trehan A, Bansal D, Chhabra S, Kaur J et al (2015) Impact of iron deficiency on hemoglobin A2% in obligate β-thalassemia heterozygotes. Int J Lab Hematol 37:105–111CrossRef
Metadata
Title
HbE Level and Red Cell Parameters in Heterozygous HbE With and Without α0-Thalassemia Trait
Authors
Sakorn Pornprasert
Monthathip Tookjai
Manoo Punyamung
Panida Pongpunyayuen
Publication date
01-10-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-0947-8

Other articles of this Issue 4/2018

Indian Journal of Hematology and Blood Transfusion 4/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine